✦ LIBER ✦

Depletion of l-ascorbic acid alternating with its supplementation in the treatment of patients with acute myeloid leukemia or myelodysplastic syndromes

✍ Scribed by Chan H. Park; Bruce F. Kimler; Seong Yoon Yi; Se Hoon Park; Kihyun Kim; Chul Won Jung; Sun Hee Kim; Eun Ryung Lee; Miyong Rha; Seonwoo Kim; Mary H. Park; Sook J. Lee; Hye K. Park; Mark H. Lee; Sung Soo Yoon; Yoo Hong Min; Bong Seog Kim; Jeong-A. Kim; Won Seog Kim

Book ID: 114794579
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 159 KB
Volume: 83
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.2009.01252.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intensive treatment of elderly patients

Intensive treatment of elderly patients with acute myeloid leukemia or myelodysplastic syndrome: A single center experience in 63 patients

✍ Ciceri, F.; Messina, C.; Carrabba, M.; Tassara, E. Sala Michela; Giglio, F.; Pav 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 70 KB

183 Results of treatment in patients wit

183 Results of treatment in patients with acute myeloid leukemia preceeded by primary myelodysplastic syndrome

✍ H. Urbańska-Ryś; E. Krykowski; A. Fronczak; A. Wrzesień-Kuś; M. Blasińska-Morawi 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 118 KB

Effectiveness and safety of different az

Effectiveness and safety of different azacitidine dosage regimens in patients with myelodysplastic syndromes or acute myeloid leukemia

✍ García-Delgado, Regina; de Miguel, Dunia; Bailén, Alicia; González, José Ramón; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 611 KB

Factors influencing the pharmacokinetics

Factors influencing the pharmacokinetics of prophylactic posaconazole oral suspension in patients with acute myeloid leukemia or myelodysplastic syndrome

✍ Vehreschild, J. J.; Müller, C.; Farowski, F.; Vehreschild, M. J. G. T.; Cornely, 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 367 KB

5-Azacytidine for the treatment of patie

5-Azacytidine for the treatment of patients with acute myeloid leukemia or myelodysplastic syndrome who relapse after allo-SCT: a retrospective analysis

✍ Czibere, A; Bruns, I; Kröger, N; Platzbecker, U; Lind, J; Zohren, F; Fenk, R; Ge 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 253 KB

The clinical significance of soluble CD8

The clinical significance of soluble CD86 levels in patients with acute myeloid leukemia and myelodysplastic syndrome

✍ Barry D. Hock; Judith L. McKenzie; William Nigel Patton; Lisa F. Haring; Ying Ya 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB 👁 2 views

## Abstract ## BACKGROUND Levels of the soluble form of CD86 (sCD86) are elevated in a proportion of patients with leukemia. Although it is a potential modulator of antitumor responses, the significance of sCD86 in patients with hematologic malignancies is unknown. ## METHODS The authors evaluat